samedan logo
 
 
 
spacer
home > pmps > summer 2020 > the trend towards continuous improvement
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Trend Towards Continuous Improvement

Fabian Stöcker: I think there has been a lot of innovation, particularly in the last five to seven years. One major trend in packaging is that it was previously offered in what we would call a ‘bulk format’, this means the packaging was not washed or pre-sterilised. Now, we are seeing improvements in the supply chain.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Fabian Stöcker joined SCHOTT AG in 2012 and is Vice President Global Strategy and Innovation for the SCHOTT Business Unit Pharmaceutical Systems. Within the management team, he is responsible for strategy, product management, product development, IP management, and market intelligence covering ampoules, cartridges, pre-filled syringes, and vials for injectable use. Prior to this, he was heading the corporate strategy department of SCHOTT AG, responsible for corporate development, strategic planning, and portfolio management. Fabian studied business administration at the University of Cologne, Germany, and the Corvinus University of Budapest, Hungary. He also holds an MBA from the University of Cologne and is a Chartered Financial Analyst (CFA) charter holder from the CFA Institute, US.
spacer
Fabian Stöcker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Optimizing pharmaceutical processes

An increase in requirements from regulatory agencies around the world, combined with a growing demand for drugs in prefilled injections systems – a trend that industry experts have projected will continue – has led pharmaceutical and biotech supply chains to gain in significance. Well established and optimized processes are crucial for offering uninterrupted market supply. To satisfy its customers a CDMO must foster flexibility, efficiency and safety throughout the entire supply chain. The most important goal for all parties involved in the bio-pharma business is maximization of product quality where even small decisions can make a big difference. Future-oriented pharma processes can add value to any compound.
More info >>

White Papers

How To Increase Efficiency, Customer Satisfaction and Reduce Cost

AC Labels

A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement